Title

探討K20E對於在體內以及體外抑制血管新生之作用機轉

Translated Titles

The inhibition mechanism of compound "K20E" on Angiogenesis: in vitro and in vivo

Authors

林文馨

Key Words

血管新生 ; Angiogenesis

PublicationName

中國醫藥大學藥學系博士班學位論文

Volume or Term/Year and Month of Publication

2013年

Academic Degree Category

碩士

Advisor

吳介信

Content Language

繁體中文

Topic Category 醫藥衛生 > 藥理醫學
藥學院 > 藥學系碩士班
Reference
  1. 2. Rita Nahta, Dihua Yu, Mien-Chie Hung, Gabriel N Hortobagyi and Francisco J Estev. Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nature clinical practice, 3 (2006) 269-280.
    連結:
  2. 3. S. Vignot, S. Faivre, D. Aguirre, E. Raymond. mTOR-targeted therapy of cancer with rapamycin derivatives. Animals of Oncology, 16 (2005) 525-537.
    連結:
  3. 5. Giatromanolaki A, Sivridis E, Koukourakis M.I. Angiogenesis in colorectal cancer: prognostic and therapeutic implications. American Journal of Clinical Oncology, 29 (2006) 408-417.
    連結:
  4. 6. Bourboulia D, Stetler-Stevenson W.G. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Seminars in Cancer Biology, 20 (2010) 161-168.
    連結:
  5. 10. Ferrara N, Kerbel R.S. Angiogenesis as a therapeutic target. Nature, 438 (2005) 967-974.
    連結:
  6. 11. Folkman J. Tumor angiogenesis: therapeutic implications. The New England Journal of Medicine, 285 (1971) 1182-1186.
    連結:
  7. 12. Nyberg P, Xie L and Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Research, 65 (2005) 3967-3979.
    連結:
  8. 13. Naumov G.N, Folkman J, Straume O. Tumor dormancy due to failure of angiogenesis: role of the microenvironment. Clinical and Experimental Metastasis, 26 (2009) 51-60.
    連結:
  9. interactions and tumor dormancy. Acta Pathologica Microbiologica Scandinavica, 116 (2008) 569-585.
    連結:
  10. 15. Napoleone Ferrara, Robert S Kerbe. Angiogenesis as a therapeutic target. Nature, 438 (2005) 967-974.
    連結:
  11. 16. North S, Moenner M, Bikfalvi A. Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. Cancer Latter, 218 (2005) 1-14.
    連結:
  12. 17. Pandya N.M, Dhalla N.S, Santani D.D. Angiogenesis--a new target for future therapy. Vascular Pharmacology, 44 (2006) 265-274.
    連結:
  13. 18. RS Schwartz, WD Edwards, KC Huber, LC Antoniades, KR Bailey, AR Camrud, MA Jorgenson, DR Holmes Jr. Coronary restenosis: prospects for solution and new perspectives from a porcine model. Mayo Clinic Proceedings, 68 (1993) 54-62.
    連結:
  14. 19. AJ Carter, JR Laird, A Farb, W Kufs, DC Wortham, R Virmani. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. Journal of the American College of Cardiology, 24 (1994) 1398-1405.
    連結:
  15. 20. MJ Post, C Borst, G Pasterkamp, CC Haudenschild. Arterial remodeling in atherosclerosis and restenosis: a vague concept of a distinct phenomenon. Atherosclerosis, 118 (1995) 115-123.
    連結:
  16. 21. RS Schwartz, DR Holmes Jr, EJ Topol. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. Journal of the American College of Cardiology, 20 (1992) 1284-1293.
    連結:
  17. 22. Jen-Chine Wu, Horng-Chin Yan, Wei-Teing Chen, Wei-Hwa Chen, Chia-Jen Wang, Ying-Chih Chi, Woei-Yau Kao, JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC. EXPERIMENTAL CELL RESEARCH, 314 (2008) 421-429.
    連結:
  18. 24. Kitagawa Y, Dai J, Zhang J, et al. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Research, 65 (2005) 10921–9.
    連結:
  19. 25. Strauss B.H, Chisholm R.J, Keeley F.W, Gotlieb A.I, Loqan R.A. Armsronq P.W. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circulation Research, 75 (1944) 650-658.
    連結:
  20. 26. Ohbayashi H. Matrix metalloproteinases in lung diseases. Current Protein and Peptide Science, 3(2002) 409-421.
    連結:
  21. 27. Bourboulia D, Stetler-Stevenson W.G. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Seminars in Cancer Biology, 20 (2010) 161-168.
    連結:
  22. 28. Westermarck J, Kähäri V.M. Regulation of matrix metalloproteinase expression in tumor invasion. The FASEB Journal, 13 (1999) 781-792.
    連結:
  23. 29. Roy R., Zhanq B, Moses M.A. Making the cut: protease-mediated regulation of angiogenesis. Exp. Cell Research, 312 (2006) 608-622.
    連結:
  24. 30. McCawley L.J, Matrisian L.M. Matrix metalloproteinases: multifunctional contributors to tumor progression. Molecular Medicine Today, 6 (2000) 149-156.
    連結:
  25. 31. Newby A.C. Matrix metalloproteinases regualte migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovascular Research, 69 (2006) 614-624.
    連結:
  26. 32. Raghu Adya, Bee K. Tan, Anu Punn, Jing Chen, and Harpal S. Randeva. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovascular Research, 78 (2008) 356–365.
    連結:
  27. 33. Kyung Hee Jung, Hong-Mei Zheng, Yujeong Jeong, Myung-Joo Choi, Hyunseung Lee, Sang-Won Hong, Hee-Seung Lee, Mi Kwon Son, Soyoung Lee, Sungwoo Hong, Soon-Sun Hong. Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor. Cancer Latters, 328 (2013) 176-187.
    連結:
  28. 34. Jeong-Eun Huh , Yong-Hyeon Baek , Min-Ho Lee , Do-Young Choi , Dong-Suk Park , Jae-Dong Lee. Bee venom inhibits tumor angiogenesis and metastasis by inhibiting. Cancer Letters, 292 (2010) 98–110.
    連結:
  29. 35. YOSHIYUKI KIMURA AND HIROMICHI OKUDA. Effects of Naturally Occurring Stilbene Glucosides from Medicinal Plants and Wine, on Tumour Growth and Lung Metastasis in Lewis Lung Carcinoma-Bearing Mice. Journal of Pharmacy and Pharmacology, 52 (2000) 1287-1296.
    連結:
  30. 36. Kalli Koniaras, Andrew R Cuddihy, Helen Christopoulos, Annette Hogg and Matthew J O'Connell. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene, 20 (2011) 7453-7463.
    連結:
  31. 37. Carolyn Cao, Eric T. Shinohara, Ty K. Subhawong, et al. Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2. Molecular Cancer Therapeutics, 5 (2006) 411-417.
    連結:
  32. 38. Gopalsamy R.G, Savarimuthu I, Michael G.P, Ponnusamy S. Antihyperglycemic activity and antidiabetic effect of methyl caffeate isolated from Solanum torvum Swartz. fruit in streptozotocin induced diabetic rats. European Journal of Pharmacology, 670 (2011) 623-631.
    連結:
  33. 39. Balachandran C, Duraipandiyan V, Abdulah Al-Dhabi N, Balakrishna K, Kalia N.P, Rajput V.S., Khan I.A, Ignacimuthu S. Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit. Indian Journal of Microbiology, 52 (2012) 676-681.
    連結:
  34. 40. Xia C.N, Li H.b, Liu F, Hu W.X. Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines. Bioorganic and Medicinal Chemistry Letters, 18 (2008) 6553-6557.
    連結:
  35. 41. Masuda T, Yamada K, Akiyama J, Someya T, Odaka Y, Takeda Y, Tori M, Nakashima K, Maekawa T, Sone Y. Antioxidation Mechanism Studies of Caffeic Acid: Identification of Antioxidation Products of Methyl Caffeate from Lipid Oxidation. Journal of Agricultural and Food Chemistry, 56 (2008) 5947-5952.
    連結:
  36. 42. Mohan M, Jaiswal B.S, Kasture S. Effect of Solanum torvum on blood pressure and metabolic alterations in fructose hypertensive rats. Journal of Ethnopharmacology, 126 (2009) 86-89.
    連結:
  37. 43. Manoj Kumar Gupta, Ren-Yi Qin. Mechanism and its regulation of tumor-induced angiogenesis. World Journal of Biological Chemistry, 9 (2003) 1144-1155.
    連結:
  38. 44. Tim Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65 (1983) 55-63.
    連結:
  39. 46. Brian J. Reid, M.D., Ph.D., Douglas S. Levine, M.D., Gary Longton, M.S., Patricia L. Blount, M.D., and Peter S. Rabinovitch, M.D., Ph.D. Predictors of Progression to Cancer in Barrett’s Esophagus:Baseline Histology and Flow Cytometry Identify Low- and High-Risk Patient Subsets. American Journal of Gastroenterology, 95 (2000) 1669–1676.
    連結:
  40. 47. RUDOLF I. AMANN, BRIAN J. BINDER, ROBERT J. OLSON, SALLIE W. CHISHOLM, RICHARD DEVEREUX, AND DAVID A. STAHL. Combination of 16S rRNA-Targeted Oligonucleotide Probes with Flow Cytometry for Analyzing Mixed Microbial Populations. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 56 (1990) 1919-1925.
    連結:
  41. 48. Chun-Chi Liang, Ann Y Park and Jun-Lin Guan, In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature Protocols, 2 (2007) 329-333.
    連結:
  42. 49. Rodriguez L.G, Wu X., Guan J.L. Wound-healing assay. Methods in Molecular Biology, 294 (2005) 23-29.
    連結:
  43. 50. TIMOTHY McKINNON, CHANDAN CHAKRABORTY, LOUISE M. GLEESON, PETER CHIDIAC, ANDPEEYUSH K. LALA. Stimulation of Human Extravillous Trophoblast Migration by IGF-II Is Mediated by IGF Type 2 Receptor Involving Inhibitory G Protein(s) and Phosphorylation of MAPK. The Journal of Clinical Endocrinology and Metabolism, 86 (2001) 3665-3674.
    連結:
  44. 51. Patrick Au, Joshua Tam, Dai Fukumura and Rakesh K. Jain. Bone marrow-d erived mesenchymal stem cells facilitate engineering of ong-lasting functional vasculature. Journal of the American society of hematology, 111 (2008) 4551-4558.
    連結:
  45. 52. J Marshall. Transwell○R Invasion assay. Methods in Molecular Biology, 769 (2011) 97-110.
    連結:
  46. 53. Arnaoutova I, George J, Kleinman H.K, Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis, 12 (2009) 267-274.
    連結:
  47. 54. Injune Kim, Hwan Gyu Kim, Sang-Ok Moon, Soo Wan Chae, June-No So, Keum Nim Koh, Byung Cook Ahn and Gou Young Koh. Angiopoietin-1 Induces Endothelial Cell Sprouting Through the Activation of Focal Adhesion Kinase and Plasmin Secretion. Circulation Research, 86 (2000) 952-959.
    連結:
  48. 56. Brooks PC, Montgomery AM, Cheresh DA. Use of the 10-day-old chick embryo model for studying angiogenesis. Methods in Molecular Biology, 69 (1999) 129-257.
    連結:
  49. 58. Mike F. Burbridge, David C. West. Rat aortic ring: 3D model of angiogenesis in vitro. Angiogenesis protocols, 46 (2001) 185–204.
    連結:
  50. 59. Jeong-Eun Huh , Yong-Hyeon Baek , Min-Ho Lee , Do-Young Choi , Dong-Suk Park , Jae-Dong Lee. Bee venom inhibits tumor angiogenesis and metastasis by inhibiting. Cancer Letters, 292 (2010) 98–110.
    連結:
  51. 60. YOSHIYUKI KIMURA AND HIROMICHI OKUDA. Effects of Naturally Occurring Stilbene Glucosides from Medicinal Plants and Wine, on Tumour Growth and Lung Metastasis in Lewis Lung Carcinoma-Bearing Mice. Journal of Pharmacy and Pharmacology, 52 (2000) 1287-1296.
    連結:
  52. 61. Di Chen, Kristin R Landis-Piwowar, Marina S Chen and Q Ping Dou. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Research article, 9 (2007) 1186-1193.
    連結:
  53. 62. PAUL J. SHUGHRUE, DENNIS B. LUBAHN, ANDRES NEGRO-VILAR, KENNETH S. KORACH,AND ISTVAN MERCHENTHALER. Responses in the brain of estrogen receptor a-disrupted mice. PNAS, 94 (1997) 11008-11012.
    連結:
  54. 63. T.H. Vu, J.M. Shipley, G. Bergers, J.E. Berger et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell, 93 (1998) 411–422.
    連結:
  55. 64. G. Bergers, R. Brekken, G. McMahon, T.H. Vu et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biology, 2 (2000) 737–744.
    連結:
  56. 66. Jordan, M. A.; Wilson, L. Micrutubules as a Target for Anticancer Drugs. Nature Reviews Cancer, 4 (2004) 253-265.
    連結:
  57. 67. Nam, N. H. Combretastatin A-4 Analogues as Antimitotic Antitumor Agents. Current Medicinal Chemistry, 10 (2003) 1697-1722.
    連結:
  58. 69. Mekhail, T. M.; Markman, M. Paclitaxel in cancer therapy. Expert Opin Pharmacother, 3 (2002) 755-766.
    連結:
  59. 70. Kirschner, L. S.; Greenberger, L. M.; Hsu, S. I.-H.; Yang, C.-P. H.; Cohen, D.; Piekarz, R. L.; Castillo, G.; Han, E. K.-H. H.; Yu, L.; Horwitz, S. B. Biochemical and genetic characterization of the multidrug resistance phenotype in murine macrophage-like J774.2 cells. Biochem Pharmacology, 43 (1992) 77.
    連結:
  60. 71. Gottesman, M. M. Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 62 (1993) 385.
    連結:
  61. 1. Calvin D. Roskelley, David E. Williams, Lianne M. McHardy, Kevin G. Leong, Armelle Troussard, Aly Karsan, Raymond J. Andersen, Shoukat Dedhar, and Michel Roberge. Inhibition of Tumor Cell Invasion and Angiogenesis by Motuporamines. Cancer Research, 61 (2001) 6788 – 6794.
  62. 4. Dong M. Shin, Nicholas J. Donato, Roman Perez-Soler, et al. Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer. Clinical Cancer Research, 7 (2001) 1204-1213.
  63. 7. 行政院衛生署http://www.doh.gov.tw/cht2006/index_populace.aspx
  64. 8. 世界衛生組織http://www.who.int/en/
  65. 9. Griffioen A.W, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacology Reviews, 52 (2000) 237-268.
  66. 14. Naumov G.N, Folkman J, Straume O, Akslen LA. Tumor-vascular
  67. 23. 榮民總醫院內科部血液腫瘤科主治醫師卅顏厥全。http://www.youth.com.tw/db/epaper/es002001/N97.04.07-F.htm
  68. 45. Sladowski D, Steer S.J, Clothier R.H, Balls M. An improved MTT assay. Journal of Immunological Methods, 157 (1993) 203-207.
  69. 55. Douglas C. Lee, Christopher J. Stenland, Randal C. Hartwell,Elizabeth K. Ford, Kang Cai, Jeanette L.C. Miller, Kevin J. Gilligan, Richard Rubenstein, Michael Fournel, Stephen R. Petteway J. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. Journal of Virological Methods, 84 (2000) 77-89.
  70. 57. Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest, 22 (1990) 63-115.
  71. 65. Zaharevitz, D. W.; Gussio, R.; Leost, M.; Senderowicz, A.M.; Lahusen, T.; Kunick, C.; Meijer, L.; Sausville, E. A. Discovery and initial characterization of the paullones, anovel class of small-molecule inhibitors of cyclindependent kinases. Cancer Research, 59(1999) 2566-2569.
  72. 68. Yoshimatsu, K.; Yamaguchi, A.; Yoshino, H.; Koyanagi, N; Kitoh, K. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin. Cancer Research, 57 (1997) 3208-3213.